BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1108 related articles for article (PubMed ID: 26756400)

  • 21. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
    Chen F; David D; Ferrari A; Götz J
    Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
    Iijima-Ando K; Iijima K
    Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport.
    Butler VJ; Salazar DA; Soriano-Castell D; Alves-Ferreira M; Dennissen FJA; Vohra M; Oses-Prieto JA; Li KH; Wang AL; Jing B; Li B; Groisman A; Gutierrez E; Mooney S; Burlingame AL; Ashrafi K; Mandelkow EM; Encalada SE; Kao AW
    Hum Mol Genet; 2019 May; 28(9):1498-1514. PubMed ID: 30590647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic modifiers of tauopathy in Drosophila.
    Shulman JM; Feany MB
    Genetics; 2003 Nov; 165(3):1233-42. PubMed ID: 14668378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of dMyc mitigates Tau
    Pragati ; Chanu SI; Sarkar S
    Neurosci Lett; 2020 Jan; 715():134622. PubMed ID: 31715291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.
    Jiang Y; MacNeil LT
    Mol Neurodegener; 2023 Nov; 18(1):82. PubMed ID: 37950311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration.
    Ding Y; Lei L; Lai C; Tang Z
    J Alzheimers Dis; 2019; 69(2):339-353. PubMed ID: 31006683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studying tauopathies in Drosophila: A fruitful model.
    Sun M; Chen L
    Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
    Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
    Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of tauopathies by comparing Drosophila and human tau in Drosophila.
    Chen X; Li Y; Huang J; Cao D; Yang G; Liu W; Lu H; Guo A
    Cell Tissue Res; 2007 Jul; 329(1):169-78. PubMed ID: 17406902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hSOD1 promotes tau phosphorylation and toxicity in the Drosophila model.
    Huang Y; Wu Z; Zhou B
    J Alzheimers Dis; 2015; 45(1):235-44. PubMed ID: 25524953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Tau Toxicity Modifiers in the Drosophila Eye.
    Dourlen P
    Methods Mol Biol; 2017; 1523():375-389. PubMed ID: 27975266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disentangling the role of the tau gene locus in sporadic tauopathies.
    Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R
    Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
    Strang KH; Golde TE; Giasson BI
    Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.